Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Conmed Corp Reaffirms FY 2013 EPS Guidance; Updates FY 2013 Revenue Guidance To A Range Below Analysts' Estimates


Thursday, 14 Feb 2013 07:00am EST 

Conmed Corp announced that for fiscal 2013, it expects earnings per share in the range of $1.80-$1.90 on estimated sales of $785-$795 million. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $1.85 on revenue of $796 million for fiscal 2013. 

Company Quote

43.86
-0.4 -0.90%
11 Jul 2014